EGCG inhibited MIA PaCa-2 and Panc-1 pancreatic cancer migration and invasion in vitro and in vivo through modulation of EMT demonstrated via the prevention of cadherin switch as well as a decrease in TCF8/ZEB1, β-Catenin and vimentin expression. The gene discussed is ZEB1; the disease is familial pancreatic carcinoma.